Drug Type ASO |
Synonyms- |
Target |
Mechanism HJV inhibitors(Hemochromatosis type 2 protein inhibitors), Hepc inhibitors(Hepcidin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia | Preclinical | - | - | |
Anemia | Preclinical | - | - |